不同超声系统及操作者间肝脏脂肪变性衰减系数测量的一致性研究
这项前瞻性研究在26例不同程度肝脏脂肪变性受试者中,用8套不同厂商的超声系统由2名操作者分别测量衰减系数(AC),并与MRI质子密度脂肪分数(PDFF)对照。结果显示不同系统间AC值一致性总体较差(总体ICC=0.33),仅1对系统达良好一致,5种算法与MRI PDFF相关性高;操作者间一致性从中等到极好不等。
要点
- 不同厂商超声系统测得的AC值一致性总体差(总体ICC=0.33),系统间不可互换用于脂肪肝诊断与随访。
- 8种AC算法中5种与MRI PDFF相关性高(r=0.70-0.86),2种中等(r=0.62),1种差(r=0.47)。
- 操作者间AC一致性因算法而异,三星Medison算法极好(ICC=0.90),西门子与佳能良好(ICC均=0.76)。
核心结论
- 不同超声系统获得的AC值存在substantial变异,系统间不可互换用于肝脏脂肪变性诊断和随访成像;操作者间一致性从中等到极好。
研究设计与样本
- 前瞻性研究,2023年9月30日至10月1日在俄亥俄州Youngstown的Southwoods Imaging进行,纳入26例(平均年龄55.4岁±10.7,16例女性),2名操作者独立使用8套不同厂商带AC算法的超声系统测量,同日由另一操作者行MRI PDFF测量,采用混合效应模型评估US AC与MRI PDFF相关性,ICC评估系统间与操作者间一致性。
诊断标准与关键数值
- 5种AC算法与MRI PDFF相关性高(r范围0.70-0.86),2种中等(r均=0.62),1种差(r=0.47)。
- 系统间成对比较总体ICC=0.33(95%CI:0.15,0.52),无一对达极好一致;1对良好(ICC=0.79,95%CI:0.66,0.87),8对中等(ICC范围0.50〔95%CI:0.22,0.69〕至0.73〔95%CI:0.49,0.85〕),19对差(ICC范围0.11〔95%CI:-0.06,0.37〕至0.48〔95%CI:0.20,0.67〕)。
- 操作者间AC一致性:三星Medison算法极好(ICC=0.90,95%CI:0.80,0.96),西门子Healthineers与佳能Medical Systems算法良好(ICC均=0.76,95%CI分别为0.54,0.89和0.16,0.92),其余算法中等(ICC范围0.50〔95%CI:0.16,0.73〕至0.74〔95%CI:0.51,0.88〕)。
临床应用与阅片要点
- 不同厂商超声系统的AC值不可互换,随访脂肪变性时应使用同一系统与算法。
- 操作者间一致性因算法而异,三星Medison算法操作者间一致性极好,佳能算法置信区间宽(95%CI:0.16,0.92)。
- 除佳能Medical Systems系统外,两台操作者所得平均AC值在各系统间无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The extent of liver steatosis can be assessed using US attenuation coefficient (AC) algorithms currently implemented in several US systems. However, little is known about intersystem and interoperator variability in measurements. Purpose To assess intersystem and interoperator agreement in US AC measurements for fat quantification in individuals with varying degrees of liver steatosis and to assess the correlation of each manufacturer's AC algorithm results with MRI proton density fat fraction (PDFF). Materials and Methods This prospective study was conducted at Southwoods Imaging, Youngstown, Ohio, September 30-October 1, 2023. Two operators independently obtained AC measurements using eight US systems equipped with an AC algorithm from different manufacturers. On the same day, MRI PDFF measurement was performed by a different operator. Correlation between US AC and MRI PDFF was assessed using a mixed-effects model. Agreement between systems and operators was evaluated using the intraclass correlation coefficient (ICC). Results Twenty-six individuals (mean age, 55.4 years ± 10.7 [SD]; 16 female participants) were evaluated. The correlation of US AC with MRI PDFF was high for five AC algorithms (r range, 0.70-0.86), moderate for two (r = 0.62 for both), and poor for one (r = 0.47). In pairwise comparisons, none of the pairs of systems achieved excellent agreement (overall ICC = 0.33 [95% CI: 0.15, 0.52]). One pair showed good agreement (ICC = 0.79 [95% CI: 0.66, 0.87]), eight pairs showed moderate agreement (ICC range, 0.50 [95% CI: 0.22, 0.69] to 0.73 [95% CI: 0.49, 0.85]), and 19 pairs showed poor agreement (ICC range, 0.11 [95% CI: -0.06, 0.37] to 0.48 [95% CI: 0.20, 0.67]). Interoperator agreement on AC value was excellent for the Samsung Medison algorithm (ICC = 0.90 [95% CI: 0.80, 0.96]), good for the Siemens Healthineers (ICC = 0.76 [95% CI: 0.54, 0.89]) and Canon Medical Systems (ICC = 0.76 [95% CI: 0.16, 0.92]) algorithms, and moderate for the remaining algorithms (ICC range, 0.50 [95% CI: 0.16, 0.73] to 0.74 [95% CI: 0.51, 0.88]). The mean AC value obtained by the two operators did not differ for any system except the system from Canon Medical Systems. Conclusion There was substantial variability in AC values obtained with different US systems, precluding interchangeability between systems for liver steatosis diagnosis and follow-up imaging. Interoperator agreement ranged from moderate to excellent. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Han in this issue.
引用
- Ferraioli G, Roccarina D, Barr RG, et al. Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis. Radiology. 2024. PMID: 39470421. doi:10.1148/radiol.240162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。